Form 4 for BC BRUNSWICK CORP
Accepted 2025-02-04 00:00:00 ET · period of report 2025-01-31 · accession 0000014930-25-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-04 | 2025-01-31 | BC | MCCLANATHAN JOSEPH W | Dir | A - Grant | $67.44 | +1,111 | 21.4K | +5% | +$74.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-31 | A | A | 1,111 | $67.44 | 21,371 | D | — | — | (F1) 490 of these shares are deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company. (F2) Beneficial holdings include 103 shares acquired pursuant to dividend reinvestment in December 2024. |